方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 药物警戒PRR/ROR× | 群体药效学模型× | |
|---|---|---|
| 领域 | 药理学 | 药理学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2002 | 1992 |
| 提出者≠ | Arne Melander and colleagues | Lewis Sheiner and Stephen Roush |
| 类型≠ | safety signal detection | dose-response modeling |
| 开创性文献≠ | Szarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| 别名≠ | PRR, ROR, signal detection, adverse event monitoring | PopPD, population PD, hierarchical PD modeling |
| 相关 | 3 | 3 |
| 摘要≠ | Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGate数据集 ↗ |
|
|